Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question to milestone or anyone who knows,

When any US stock is acquired this is what the response to me from the SEC was...

Dear Mr.

Thank you for contacting the SEC.

When a person or group of persons acquires beneficial ownership of more than 5% of a class of a company?s equity securities registered under Section 12 of the Securities Exchange Act of 1934, they must file a Schedule 13D (or in some cases, Schedule 13G) with the SEC. More information about this requirement is available on the SEC website at http://www.sec.gov/answers/sched13.htm.

In addition, a company's officers and directors, and any beneficial owners of more than ten percent of a class of the company's equity securities registered under Section 12 of the Securities Exchange Act of 1934, must file a statement of ownership regarding those securities with the SEC. Information about this requirement can be found on our website at http://www.sec.gov/answers/form345.htm.Institutional investment managers who exercise investment discretion over $100 million or more in Section 13(f) securities must report their holdings on Form 13F with the SEC. (See

http://www.sec.gov/answers/form13f.htm.)

I hope this information will prove helpful to you.

Sincerely,

BONNIE C DAILEY

Senior Counsel

Office of Investor Education and Advocacy

U.S. Securities and Exchange Commission

100 F St, NE

Washington, DC 20549-0213

Share
New Message
Please login to post a reply